Quest Diagnostics (DGX) Q1 FY2026 earnings: revenue $2.9 billion, up 9.2% on the year
Quest Diagnostics Inc. (DGX) reported revenue of $2.9 billion for Q1 FY2026, the quarter ended 31 March 2026, up 9.2% on the same quarter a year earlier. Net income was $252 million, up 14.5% on the year, and diluted earnings per share $2.24. The figures are the company's own, from the 10-Q it filed with the SEC on 22 April 2026.
Revenue
$2.9 billion
+9.2% on the year · +3.2% on the quarter
Q2 FY2024Q1 FY2026
Operating margin
13.8%
13.0% a year earlier
Q2 FY2024Q1 FY2026
Net income
$252 million
+14.5% on the year · +2.9% on the quarter
Q2 FY2024Q1 FY2026
Diluted EPS
$2.24
+15.5% on the year · +2.8% on the quarter
Q2 FY2024Q1 FY2026
this quarterthe same quarter a year earlierHover a bar for its figure.
What management said
Guidance figures: 4 raised, 2 kept.
Revenue rose 9.2% in quarter: Net revenues were $2,895 million, up 9.2% from $2,652 million, with the company citing 9.0% organic revenue growth.
Diluted EPS rose 15.5% on reported basis: Reported diluted EPS was $2.24, up 15.5% from $1.94; adjusted diluted EPS was $2.50, up 13.1% from $2.21.
Requisition volume rose 10.9%: Requisition volume increased 10.9%, and organic requisition volume increased 10.8%.
$ million except per share. Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
Q1 FY2026
Q4 FY2025
Q1 FY2025
On the quarter
On the year
Last 8 quarters
Operating cash flow
278
465
314
-40.2%
-11.5%
Capital expenditure
114
158
117
-27.8%
-2.6%
Free cash flow
164
307
197
-46.6%
-16.8%
Free cash flow margin
5.7%
10.9%
7.4%
Cash from investing
-152
-191
-115
Cash from financing
-152
-287
-561
Depreciation and amortisation
147
145
140
+1.4%
+5.0%
Share-based compensation
20.0
25.0
22.0
-20.0%
-9.1%
Dividends paid
88.0
90.0
84.0
-2.2%
+4.8%
Dividend per share
$0.86
$0.80
$0.80
+7.5%
+7.5%
Diluted shares, weighted
112m
112m
113m
0.0%
-0.9%
Shares outstanding at period end
111m
110m
112m
+0.8%
-0.8%
Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.
Balance sheet
$ million
Q1 FY2026
Q4 FY2025
Q1 FY2025
On the quarter
On the year
Last 8 quarters
Shareholders' equity
7,366
7,170
6,929
+2.7%
+6.3%
Non-controlling interest
300
36.0
33.0
+733.3%
+809.1%
Redeemable equity
79.0
80.0
81.0
-1.2%
-2.5%
Debt
5,658
5,671
5,858
-0.2%
-3.4%
Operating lease liabilities
574
537
538
+6.9%
+6.7%
Finance lease liabilities
n/a
18.0
n/a
Other liabilities
2,696
2,713
2,358
-0.6%
+14.3%
Total liabilities and equity
16,673
16,225
15,797
+2.8%
+5.5%
Fixed assets
2,189
2,203
2,098
-0.6%
+4.3%
Goodwill
9,120
8,945
8,849
+2.0%
+3.1%
Intangible assets
1,717
1,636
1,725
+5.0%
-0.5%
Securities held for sale or to maturity
n/a
0.0
n/a
Trading assets
84.0
78.0
n/a
+7.7%
Cash and equivalents
393
420
188
-6.4%
+109.0%
Receivables
1,587
1,408
1,404
+12.7%
+13.0%
Inventory
225
189
189
+19.0%
+19.0%
Other assets
1,358
1,346
1,344
+0.9%
+1.0%
Total assets
16,673
16,225
15,797
+2.8%
+5.5%
Questions
What was Quest Diagnostics' revenue in Q1 FY2026?
Quest Diagnostics (DGX) reported revenue of $2.9 billion for Q1 FY2026, the quarter ended 31 March 2026, up 9.2% on the same quarter a year earlier.
How much did Quest Diagnostics earn in Q1 FY2026?
Net income for Q1 FY2026 was $252 million, up 14.5% on the year, and diluted earnings per share $2.24.
When did Quest Diagnostics report Q1 FY2026 results?
Quest Diagnostics filed its 10-Q for the quarter ended 31 March 2026 with the SEC on 22 April 2026.
Each quarter as filed, linked to its filing. Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.
10-Q for the period ended 31 March 2026, filed 22 April 2026: the filing.